These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 12496955

  • 1. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
    Casey DE, Daniel DG, Wassef AA, Tracy KA, Wozniak P, Sommerville KW.
    Neuropsychopharmacology; 2003 Jan; 28(1):182-92. PubMed ID: 12496955
    [Abstract] [Full Text] [Related]

  • 2. Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia.
    Casey DE, Daniel DG, Tamminga C, Kane JM, Tran-Johnson T, Wozniak P, Abi-Saab W, Baker J, Redden L, Greco N, Saltarelli M.
    Neuropsychopharmacology; 2009 Apr; 34(5):1330-8. PubMed ID: 19052541
    [Abstract] [Full Text] [Related]

  • 3. Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.
    Citrome L, Casey DE, Daniel DG, Wozniak P, Kochan LD, Tracy KA.
    Psychiatr Serv; 2004 Mar; 55(3):290-4. PubMed ID: 15001730
    [Abstract] [Full Text] [Related]

  • 4. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR, Mahmoud R.
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [Abstract] [Full Text] [Related]

  • 5. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
    Feldman PD, Kaiser CJ, Kennedy JS, Sutton VK, Tran PV, Tollefson GD, Zhang F, Breier A.
    J Clin Psychiatry; 2003 Sep; 64(9):998-1004. PubMed ID: 14628974
    [Abstract] [Full Text] [Related]

  • 6. Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand.
    Gureje O, Miles W, Keks N, Grainger D, Lambert T, McGrath J, Tran P, Catts S, Fraser A, Hustig H, Andersen S, Crawford AM.
    Schizophr Res; 2003 Jun 01; 61(2-3):303-14. PubMed ID: 12729882
    [Abstract] [Full Text] [Related]

  • 7. Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.
    Dossenbach MR, Kratky P, Schneidman M, Grundy SL, Metcalfe S, Tollefson GD, Belmaker RH.
    J Clin Psychiatry; 2001 Jun 01; 62 Suppl 2():28-34. PubMed ID: 11232749
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X, Savage R, Borisov A, Rosenberg J, Woolwine B, Tucker M, May R, Feldman J, Nemeroff CB, Miller AH.
    J Psychiatr Res; 2006 Oct 01; 40(7):669-76. PubMed ID: 16762371
    [Abstract] [Full Text] [Related]

  • 9. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2002 Feb 01; 159(2):255-62. PubMed ID: 11823268
    [Abstract] [Full Text] [Related]

  • 10. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.
    J Clin Psychiatry; 2002 Oct 01; 63(10):931-5. PubMed ID: 12416603
    [Abstract] [Full Text] [Related]

  • 11. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
    Tollefson GD, Andersen SW.
    J Clin Psychiatry; 1999 Oct 01; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
    [Abstract] [Full Text] [Related]

  • 12. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
    Isaac MB, Isaac MT.
    Neuropsychopharmacology; 2003 Nov 01; 28(11):2049; author reply 2052-3. PubMed ID: 12968130
    [No Abstract] [Full Text] [Related]

  • 13. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L, Hamer RM, Bashford RA, Sheitman BB, Lieberman JA.
    Neuropsychopharmacology; 2004 Jan 01; 29(1):133-45. PubMed ID: 14583740
    [Abstract] [Full Text] [Related]

  • 14. Measurement of simple reaction time in antipsychotic treatment of patients with schizophrenia.
    Kores Plesnicar B, Zalar B, Tomori M, Krajnc I.
    Wien Klin Wochenschr; 2003 Jan 31; 115(1-2):58-62. PubMed ID: 12658913
    [Abstract] [Full Text] [Related]

  • 15. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
    Sacchetti E, Valsecchi P, Parrinello G, QUERISOLA Group.
    Schizophr Res; 2008 Jan 31; 98(1-3):55-65. PubMed ID: 17933497
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE, Pantelis C, Dineen M, Benattia I, Romano SJ.
    J Clin Psychiatry; 2004 Dec 31; 65(12):1624-33. PubMed ID: 15641867
    [Abstract] [Full Text] [Related]

  • 17. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
    Usall J, López-Carrilero R, Iniesta R, Roca M, Caballero M, Rodriguez-Jimenez R, Oliveira C, Bernardo M, Corripio I, Sindreu SD, González Piqueras JC, Felipe AE, Fernandez de Corres B, Ibáñez A, Huerta R, Abordaje Síntomas Negativos Esquizofrenia Group.
    J Clin Psychiatry; 2014 Jun 31; 75(6):608-15. PubMed ID: 25004184
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.
    Weiden PJ, Simpson GM, Potkin SG, O'Sullivan RL.
    J Clin Psychiatry; 2003 May 31; 64(5):580-8. PubMed ID: 12755663
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of olanzapine and risperidone in schizophrenia: a randomized double-blind crossover design.
    Canive JM, Miller GA, Irwin JG, Moses SN, Thoma RJ, Edgar JC, Sherwood A, Torres F, Lanoue M, Lewis S, Hanlon FM, Weisend MP, Mead V, Tuason VB.
    Psychopharmacol Bull; 2006 May 31; 39(1):105-16. PubMed ID: 17065975
    [Abstract] [Full Text] [Related]

  • 20. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.
    Tran PV, Hamilton SH, Kuntz AJ, Potvin JH, Andersen SW, Beasley C, Tollefson GD.
    J Clin Psychopharmacol; 1997 Oct 31; 17(5):407-18. PubMed ID: 9315992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.